top of page

PRESS RELEASE

Jan 9, 2020

Nerve-healing startup Renerva joins McGovern incubator

Renerva, a medical startup that is developing an injectable gel to speed the healing of damaged nerves and creating an off-the-shelf nerve-graft product that may spare patients life-long disability, has joined Cornell’s McGovern Center life sciences business incubator.

PRESS RELEASE

Sep 24, 2019

Renerva Receives Funding to Expand Its Peripheral Nerve Repair Technologies

NSF and NIH grants will allow Renerva to develop its second product and expand the indication for use of its revolutionary gel for healing injured nerves

PRESS RELEASE

Dec 14, 2018

Renerva Receives $2.4 Million DoD Award to Advance Its Peripheral Nerve Matrix Technology to the Clinic

Groundbreaking injectable gel helps injured peripheral nerves repair and regenerate

PRESS RELEASE

Feb 16, 2018

It Takes Nerve: Renerva Develops Peripheral Nerve Procedures

Renerva, LLC, is a rapidly-growing and innovative medical device company with a focus to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures.

PRESS RELEASE

Sep 29, 2017

Regenerative Medicine Today Podcast

Episode #175 - Dr. Lorenzo Soletti is the Co-Founder and CEO of Renerva, LLC. Dr. Bryan Brown is also the Co-Founder of Renerva, as well as an Assistant Professor in the Department of Bioengineering with a secondary appointment in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh.

bottom of page